Technology
Health
Biotechnology

Myovant Sciences

5,144

$8.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.38 (+4.94%) Today
+$0.27 (+3.34%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MYOV and other stocks, options, ETFs, and crypto commission-free!

About MYOV

Myovant Sciences Ltd., also called Myovant Sciences, is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases. Read More The company's product includes relugolix, which is an oral, once-daily and small molecule that acts as a GnRH receptor antagonist. It also develops MVT-602 a kisspeptin agonist for the treatment of female infertility. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.

CEO
Lynn Seely
Employees
167
Headquarters
London, Greater London
Founded
2016
Market Cap
659.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.27M
High Today
$8.18
Low Today
$7.70
Open Price
$7.70
Volume
588.24K
52 Week High
$26.02
52 Week Low
$4.14

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2016 IPO
UK

MYOV News

BenzingaMar 31

Why Myovant Sciences Is Trading Higher Today

Myovant Sciences Ltd (NYSE: MYOV) shares are trading higher on Tuesday, after the company, along with Gedeon Richter, announced they have entered into an exclus
93

MYOV Earnings

-$1.07
-$0.71
-$0.36
$0.00
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Estimated
— per share
Actual
Expected May 21, Pre-Market

People Also Bought

Viking Therapeutics

51,599

$4.31

-4.01%

Viking Therapeutics

51,599

$4.31

-4.01%

Inovio

221,240

$7.45

-0.93%

Intra-Cellular Therapies

3,222

$14.40

+0.35%

Aurinia Pharmaceuticals

11,175

$14.43

+0.49%

You May Also Like

SKF
MRNA
DJCI
CYB
BHF
BANC-E
DBEH
IBKCN
BBSA
CAPR
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy MYOV

Market Price$8.35
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell MYOV stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up